Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature

P Poornima, JD Kumar, Q Zhao, M Blunder… - Pharmacological …, 2016 - Elsevier
Despite massive investments in drug research and development, the significant decline in
the number of new drugs approved or translated to clinical use raises the question, whether …

[HTML][HTML] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical …

M Segovia-Mendoza… - American journal of …, 2015 - ncbi.nlm.nih.gov
An increasing number of tumors, including breast cancer, overexpress proteins of the
epidermal growth factor receptor (EGFR) family. The interaction between family members …

[HTML][HTML] Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure

L Wang, J Liu, B Xu, YL Liu, Z Liu - The Kaohsiung journal of medical …, 2018 - Elsevier
Heart failure creates a leading public health burden worldwide and cardiac fibrosis is a
hallmark of pathological cardiac remodeling which was found in HF patients. In this study …

MicroRNA expression profiling in placenta and maternal plasma in early pregnancy loss

MK Hosseini, T Gunel… - Molecular …, 2018 - spandidos-publications.com
Early pregnancy loss (EPL), also termed early miscarriage, is determined as the
unintentional expulsion of an embryo or fetus prior to the 12th week of gestation. EPL …

High expression of microRNA-143 is associated with favorable tumor immune microenvironment and better survival in estrogen receptor positive breast cancer

Y Tokumaru, M Asaoka, M Oshi, E Katsuta… - International journal of …, 2020 - mdpi.com
microRNA-143 (miR-143) is a well-known tumor suppressive microRNA that exhibits anti-
tumoral function by targeting KRAS signaling pathways in various malignancies. We …

[HTML][HTML] MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1

FY Xie, S Hosany, S Zhong, Y Jiang, F Zhang, LL Lin… - PloS one, 2017 - journals.plos.org
In many cancers, microRNA-193a (miR-193a) is a suppressor miRNA, but its underlying anti-
oncogenic activity in breast cancer is not known. In this study, we found decreased miR …

[HTML][HTML] Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients

T Xu, Q Zhou, L Che, S Das, L Wang, J Jiang, G Li… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Congestive heart failure (CHF) is a major cause of hospitalizations, morbidity, and mortality
in Western societies. In addition to optimal medical and device therapy, exercise training is …

Biosynthesis and biomedical perspectives of carotenoids with special reference to human health-related applications

M Khalid, M Bilal, HMN Iqbal, D Huang - Biocatalysis and Agricultural …, 2019 - Elsevier
Carotenoids are a group of versatile isoprenoid pigments, and bioactive constituents found
predominantly in fruits and vegetables. Carotenoids play an essential role in the prevention …

Plasma miRNA levels for predicting therapeutic response to neoadjuvant treatment in HER2-positive breast cancer: Results from the NeoALTTO trial

S Di Cosimo, V Appierto, S Pizzamiglio, P Tiberio… - Clinical cancer …, 2019 - AACR
Purpose: To investigate the potential of circulating-miRNAs (ct-miRNA) as noninvasive
biomarkers to predict the efficacy of single/dual HER2-targeted therapy in the NeoALTTO …

[HTML][HTML] Prognostic role of microRNAs in breast cancer: A systematic review

E Zografos, F Zagouri, D Kalapanida, R Zakopoulou… - Oncotarget, 2019 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) have been found to play an important role in breast cancer,
functioning either as potential oncogenes or tumor suppressor genes, but their role in the …